LETM2 and pancreatic neoplasm: Among the identified transporters, SLC39A10 and SLC30A6 mediate PDAC-specific zinc metabolic reprogramming, SLC22B5 represents a novel finding in pancreatic cancer, and SLC55A2 is associated with mitochondrial dysfunction and aggressive tumor behavior.